Zobrazeno 1 - 10
of 493
pro vyhledávání: '"Evangelos Cholongitas"'
Autor:
Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, Sushanth Jeyakumar, Nathaniel J Smith, Alon Yehoshua, Evangelos Cholongitas
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 4 (2024)
Aim: This study assessed the clinical impact and cost–effectiveness of switching from tenofovir disoproxil fumarate (TDF) to either tenofovir alafenamide (TAF) or entecavir (ETV) in a Greek chronic hepatitis B (CHB) population. Patients & methods
Externí odkaz:
https://doaj.org/article/73e29e4237dd4d5d897b699a6c640dba
Autor:
Evgenia Koureta, Evangelos Cholongitas
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Non alcoholic fatty disease (NAFLD) is the most common chronic liver disease that is managed in the liver departments. It seems that the prevalence of the disease is rising worldwide and as it has the same pathogenetic pathways with metabolic syndrom
Externí odkaz:
https://doaj.org/article/3c0def714b814073a2f7f10b1f133ff7
Autor:
Lampros G. Chrysavgis, Spyridon Kazanas, Konstantina Bafa, Sophia Rozani, Maria-Evangelia Koloutsou, Evangelos Cholongitas
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 3832 (2024)
Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretins that regulate postprandial glucose regulation, stimulating insulin secretion from pancreatic β-cells in response to food ingestion. Modified GLP-1 r
Externí odkaz:
https://doaj.org/article/f19f5af838524bcd8def0da55b05be5c
Autor:
Zhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, Andrea Mancuso, Cyriac Abby Philips, Frank Tacke, Metin Basaranoglu, Massimo Primignani, Mostafa Ibrahim, Yu Jun Wong, Filipe Gaio Nery, Rolf Teschke, Carlos Noronha Ferreira, Alberto E. Muñoz, Kanokwan Pinyopornpanish, Thierry Thevenot, Shivaram Prasad Singh, Arpan Mohanty, Sanjaya K. Satapathy, Lorenzo Ridola, Hitoshi Maruyama, Evangelos Cholongitas, Giovanni Battista Levi Sandri, Li Yang, Shalimar, Yongping Yang, Erica Villa, Aleksander Krag, Florence Wong, Rajiv Jalan, Alastair O’Brien, Mauro Bernardi, Xingshun Qi
Publikováno v:
JHEP Reports, Vol 5, Iss 8, Pp 100785- (2023)
Background & Aims: Numerous studies have evaluated the role of human albumin (HA) in managing various liver cirrhosis-related complications. However, their conclusions remain partially controversial, probably because HA was evaluated in different set
Externí odkaz:
https://doaj.org/article/b3fc9b951e9e4fe1a4eae57800e9c550
Autor:
Alexandra Tsankof, Georgios Neokosmidis, Evgenia Koureta, Stavroula Veneti, Evangelos Cholongitas, Konstantinos Tziomalos
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease and affects a considerable proportion of the general population worldwide. Obesity is a major risk factor for development and progression of NAFLD and weight loss is an e
Externí odkaz:
https://doaj.org/article/2e67a955979441fc841e33c81537b379
Autor:
Nikolaos D. Karakousis, Lampros Chrysavgis, Alkistis Papatheodoridi, Aigli-Ioanna Legaki, Panagiotis Lembessis, Evangelos Cholongitas, Antonios Chatzigeorgiou, George Papatheodoridis
Publikováno v:
Pathogens, Vol 12, Iss 3, p 394 (2023)
Background: Chronic hepatitis B virus (HBV) infection is a common chronic liver disease that is closely associated with increased morbidity and mortality. Circulating cell-free DNA (cf-DNA) and global DNA methylation, expressed as circulating levels
Externí odkaz:
https://doaj.org/article/6539015e18f7405484ba0153e56e998f
Autor:
Theodora Oikonomou, loannis Goulis, Petros Doumtsis, Theodora Tzoumari, Evangelos Akriviadis, Evangelos Cholongitas
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 126-136 (2019)
Introduction and aim. Studies carried out mainly in patients with hepatocellular carcinoma (HCC), have shown the prognostic significance of albumin-bilirubin (ALBI) grade. Recently, another predictive score incorporating platelet count into ALBI, PAL
Externí odkaz:
https://doaj.org/article/457c76077d3e4c6ba672909fb7b69112
Autor:
John Haanen, Amalia Anastasopoulou, Helen Gogas, Frosso Kostantinou, Evangelos Cholongitas, Panagiotis Diamantopoulos
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
In the evolving immune-oncology landscape, numerous patients with cancer are constantly treated with immune checkpoint inhibitors (ICPIs) but among them, only sporadic cases with pre-existing hepatitis B virus (HBV) and hepatitis C virus (HCV) are re
Externí odkaz:
https://doaj.org/article/f3259fe279f14b3f9eb240a1a17bed7e
Autor:
Paolo Antonio Ascierto, Amalia Anastasopoulou, Helen Gogas, Evangelos Cholongitas, Panagiotis Diamantopoulos, Aikaterini Gkoufa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Unleashing adaptive immunity via immune checkpoint inhibitors (ICPIs) in many cancer types led to durable antitumor responses and prolonged survivals and also added some new immune-related adverse events (irAEs) to the ‘old-fashioned’ safety prof
Externí odkaz:
https://doaj.org/article/2ebf23bc085f4e94b511d6d88dfe8b55
Autor:
Lampros Chrysavgis, Alkistis Papatheodoridi, Evangelos Cholongitas, Michael Koutsilieris, George Papatheodoridis, Antonios Chatzigeorgiou
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 16, p 8849 (2021)
The pathogenetic mechanisms involved in the progression of non-alcoholic fatty liver disease (NAFLD) have not been completely elucidated, while the significance of circulating cell-free DNA (cf-DNA) species has been rarely evaluated in NAFLD. Herein,
Externí odkaz:
https://doaj.org/article/e6f2f72f930948feb617e84322932fd9